1Department of Cancer Biology and Genetics, James Comprehensive Cancer Center, Wexner Medical Center, The Ohio State University, Columbus, Ohio. 3Pelotonia Institute for Immuno-Oncology, James ...

RAHWAY, NJ, USA I, 2024 I Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the closing of the exclusive ...

I-Mab, a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment ...

Tectonic's lead asset, TX45, is a long-acting Fc-relaxin fusion protein to treat group 2 pulmonary hypertension. Read why I'm ...

INR:3488. neet pg 2024 supreme court hearing Keros, which targets the TGF-β signaling pathway, plans to raise $86 million in ...

Pharmacodynamic assessments confirmed increased expression of interferon-γ-related signaling and cytotoxic ... Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid ...

A multi-institutional clinical trial led by the University of Navarra, Spain, found that blocking growth differentiation ...

But this notch signaling ligand is known to encourage tumor ... CTX-8371 is a bispecific antibody designed to bind both PD-1 and PD-L1, in a way acting as a more forceful immune checkpoint blocker ...

CAR T cell therapy revolutionizes oncology by using engineered T cells to target and eliminate cancer cells, improving ...